Heather Cook, formerly of H. Lundbeck A/S, has been appointed director of regulatory affairs at Pharmalink AB, the Swedish specialty pharmaceutical company. Dr Cook was previously head of regulatory development at Lundbeck and before that, global regulatory affairs director for oncology at AstraZeneca Plc. She has a PhD in zoology from the University of Toronto in Canada and is completing an MBA at the Stockholm School of Economics.
Pharmalink also announced the appointment of Marek Poszepczynski as director of business development. Mr Poszepczynski was previously lead equity analyst at Handelsbanken and before that, vice president of business Development at Karolinska Development.
Pharmalink announced the appointments on 29 October 2012.
Copyright 2012 Evernow Publishing Ltd